Potential conflict of interest: None reported.
Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease†
Version of Record online: 30 SEP 2009
Copyright © 2009 Movement Disorder Society
Volume 24, Issue 15, pages 2203–2210, 15 November 2009
How to Cite
Compta, Y., Martí, M. J., Ibarretxe-Bilbao, N., Junqué, C., Valldeoriola, F., Muñoz, E., Ezquerra, M., Ríos, J. and Tolosa, E. (2009), Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Mov. Disord., 24: 2203–2210. doi: 10.1002/mds.22594
- Issue online: 19 NOV 2009
- Version of Record online: 30 SEP 2009
- Manuscript Accepted: 17 MAR 2009
- Manuscript Revised: 11 MAR 2009
- Manuscript Received: 12 JAN 2009
- Fundacio la Marato de TV3 2006. Grant Number: N-2006-TV060510
- Spanish Neurology Society (SEN)
- Naroa Ibarretxe-Bilbao
- Spanish Ministry of Education and Science. Grant Number: AP2005-0191
- Laboratory of Experimental Neurology
Additional Supporting Information may be found in the online version of this article.
|MDS_22594_sm_SuppFig1.TIF||510K||Supporting Information Figure 1. Correlation between CSF beta-amyloid levels (expressed in pg/mL) and scores in Phonetic Fluency test in PDND patients (n= 20; r= 0.52; p= 0.04) with linear trend superimposed (linear regression: y=336.36+22.72*PhoneticFluencyScore; beta= 0.57; p= 0.08).|
|MDS_22594_sm_SuppTable1.doc||27K||Supporting Information Table 1. CSF tau and phospho-tau levels relation with verbal recognition and naming in PDD.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.